Rosok M J, Yelton D E, Harris L J, Bajorath J, Hellström K E, Hellström I, Cruz G A, Kristensson K, Lin H, Huse W D, Glaser S M
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
J Biol Chem. 1996 Sep 13;271(37):22611-8. doi: 10.1074/jbc.271.37.22611.
We have used a combinatorial mutagenesis strategy to humanize BR96, a monoclonal antibody that binds to the Lewis Y class of tumor antigens. This approach allows simultaneous assessment of hundreds of humanized variable regions to identify the molecules that best preserve affinity, thus overcoming the major drawback of current humanization procedures, the requirement to construct and analyze each humanized antibody separately. Murine residues of BR96 were mutated to human if they were solvent-exposed residues that did not participate in the formation of the antigen binding site and were not at the interface of the light and heavy chain. At positions that might be involved in binding to antigen, the choice between the murine and human residue was more difficult. Murine and human alternatives were incorporated into a combinatorial library at positions representing buried residues that might affect the structural integrity of the antigen binding site. By encoding this library of humanized BR96 Fabs in an M13 phage vector, we rapidly identified several candidates with nearly identical antigen binding, within 2-fold, of the chimeric Fab. Additional mutagenesis directed at sites suggested in the literature as potentially important for antigen binding in a similar anti-Lewis Y antibody yielded no further improvements.
我们采用了一种组合诱变策略来对BR96进行人源化改造,BR96是一种与肿瘤抗原Lewis Y类结合的单克隆抗体。这种方法允许同时评估数百个人源化可变区,以鉴定出最能保持亲和力的分子,从而克服了当前人源化程序的主要缺点,即需要分别构建和分析每个人源化抗体。如果BR96的鼠源残基是暴露于溶剂中的残基,且不参与抗原结合位点的形成,也不在轻链和重链的界面处,则将其突变为人类残基。在可能参与抗原结合的位置,选择鼠源残基还是人源残基更为困难。将鼠源和人源替代残基引入到一个组合文库中,这些位置代表可能影响抗原结合位点结构完整性的埋藏残基。通过在M13噬菌体载体中编码这个人源化BR96 Fab文库,我们迅速鉴定出了几个与嵌合Fab具有近相同抗原结合能力(相差2倍以内)的候选物。针对文献中提示的在类似抗Lewis Y抗体中对抗原结合可能重要的位点进行的进一步诱变没有带来进一步的改善。